Anzeige
Mehr »
Login
Dienstag, 30.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Uran Boom: Die Bullen starten durch - spektakuläre Kursgewinne möglich
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
106 Leser
Artikel bewerten:
(0)

Chiltern Receives 2010 Global Supplier Award From Eli Lilly and Company

LONDON, April 14, 2011 /PRNewswire/ -- Chiltern International Limited (Chiltern), a global clinical contract research organization (CRO), announced that the company received Eli Lilly and Company's 2010 Global Supplier Award in a ceremony held on 12th April 2011 at Lilly's headquarters in Indianapolis, Indiana.

The Lilly Global Supplier Award is presented annually to suppliers who have provided Lilly with competitive edge and demonstrated a measurable impact on Lilly corporate priorities through the delivery of exemplary quality, service, speed, total cost reduction and other value adds.

John Vann, Executive Vice President of Corporate Development who received the award in Indianapolis on Chiltern's behalf stated, "We are extremely honored to receive this award as it is a testimony of our commitment to deliver high quality service and measurable results to our clients."

"We are very proud of our team's achievement and to be recognized with this award for 2010, and very much appreciate the importance that Lilly continues to place on partnership, innovation, and service delivery - with measurable results to meet their corporate priorities," added Linda Christmas, Chiltern Senior Executive Vice President of Global Resourcing Solutions.

About Chiltern:

Established in 1982, Chiltern is a leading global clinical CRO with extensive experience in the management of Phase I-IV clinical trials across a broad range of therapeutic areas, functional service provision and contract staffing solutions. Chiltern has conducted trials in more than 40 countries, employs around 1,300 people globally and offers services in Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions. Chiltern prides itself as a development partner that offers flexibility, responsiveness and quality delivery. Further information is available at www.chiltern.com.

For More Information Contact:

Natalie Chong Susan Ojanen Marketing Director Marketing Executive Chiltern International Chiltern International Ltd. Inc. UK USA Tel: +44 (0) 1753 512 000 Tel: +1 (423) 968 9533 natalie.chong@chiltern.com susan.ojanen@chiltern.com

Chiltern

Web site: http://www.chiltern.com/

© 2011 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.